Ketamine is growing in popularity as a treatment for depression. But misuse of the drug is also causing serious, and ...
A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.
Boston Scientific on Thursday announced plans to acquire Penumbra, a US-based thrombectomy specialist, in a cash-and-stock ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Acquisition to expand urology offerings for people living with overactive bladderMARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific ...
The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...
Acquisition to expand urology offerings for people living with overactive bladder MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: ...
The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...
Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Investing in dividend-paying stocks is one of numerous approaches that can help you maximize your portfolio growth, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback